AlphaCrest Capital Management’s Fate Therapeutics FATE Stock Holding History

AlphaCrest Capital Management’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$287K	Buy
2021 Q4	–	Sell
2021 Q3	$424K	Sell
2021 Q2	$1.38M	Buy
2021 Q1	$250K	Buy
2020 Q4	–	Sell
2020 Q3	$420K	Buy
2020 Q2	–	Sell
2020 Q1	$210K	Buy